Page 3 - Ipos

IPO Calendar: D-Street braces for 9 new issues; Meesho, Aequs listings

IPO Calendar: Nephrocare, Park Medi World, Wakefit Innovations, and Corona Remedies, are set to open for subscription, aiming to raise a combined ₹3,735 crore

Last day! Aequs IPO closes today; subscription rises 28x, GMP at 37%

Aequs IPO subscription status: Among the investor categories, retail investors led the demand, with the portion reserved for them subscribed by 56.62 times

Final hours! Heavy NII, retail bidding boosts Meesho IPO; GMP holds steady

Meesho IPO Day 3: Check latest subscription status, grey market premium (GMP), allotment date, listing date, and other key details here

Corona Remedies IPO opens Dec 8: Bid or skip? Here's what experts suggest

Corona Remedies IPO Date: The unlisted shares of Corona Remedies were trading at ₹1,427, commanding a grey market premium of ₹365 or 34.4 per cent on Friday

Park Medi World IPO opens Dec 10; sets price band at ₹154-162: Key details

Park Medi World is eyeing ₹770 crore through the fresh issue for 47.5 million equity shares, and shareholders will be selling 9.3 million equity shares through an OFS for ₹150 crore

Stock Market close: Sensex, Nifty snap 4-day losing streak; IT shares outperform; VIX down 4%

Sensex today | Stock Market close, Thursday, Dec 4: The Nifty MidCap index rose 0.30 per cent, while the Nifty SmallCap gained 0.1 per cent

Corona Remedies IPO opens Dec 8: GMP at 31%; 5 key risks you should know

Corona Remedies IPO will be offered at a price band of ₹1,008 to ₹1,062 per share, with a lot size of 14 shares

Meesho IPO booked 3x on strong demand; should you bid too? Analysts weigh

Analysts highlight Meesho's zero-commission, asset-light business model, coupled with its multi-sided marketplace and logistics network

Nephrocare Health sets IPO price band at ₹438-460: Check key details here

Nephrocare Health IPO will open for public subscription on Wednesday, December 10 and close on Friday, December 12

Wakefit IPO: D2C growth story, key risks ahead, what investors should know

According to the RHP, Wakefit's performance is heavily dependent on its "Wakefit" brand, under which it sells mattresses, furniture and home furnishings

Retail investors drive demand for Aequs IPO on Day 1, NIIs follow; QIBs lag

Retail investors have oversubscribed their reserved portion by 6.42 times, while non-institutional investors (NIIs) have closely followed, with their segment oversubscribed by 1.45 times

Vidya Wires IPO fully subscribed: Retail investors lead demand; GMP at 12%

Vidya Wires IPO Day 1 update: Retail individual investors (RIIs) led the response, subscribing to their allocated portion 1.86 times

Corona Remedies IPO price band at ₹1,008-1,062; check dates, GMP, objective

Corona Remedies aims to raise ₹655.37 crore through an offer for sale of 6.2 million equity shares

Meesho vs Aequs vs Vidya Wires IPO: Which one should you bet on?

Analysts remain largely positive on Meesho IPO and Vidya Wires IPO, citing strong growth prospects and operational efficiency, while views on Aequs IPO are cautious

Meesho IPO opens: From price band to GMP, here's all you need to know

Meesho IPO opens today: Check price band, lot size, GMP, review, allotment date, listing date and other key details here

Debt repayment, capital expenditure: How IPO proceeds are being utilised

data on 189 IPOs where information is available show that the total amount to be raised through fresh equity was Rs 1.20 trillion, with another offer for sale (OFS) component being Rs 62,000 crore

Stock Market Close: Sensex falls 504 pts, Nifty at 26,032 amid profit-booking; financials top drag

Sensex Today | Stock Market close, Tuesday, December 02, 2025: In the broader markets, the Nifty MidCap index fell 0.22 per cent, while the Nifty SmallCap index fell 0.55 per cent

Aequs IPO opens December 3; should you bid? Check GMP, price band here

Aequs IPO to open on December 3, 2025: Aequs plans to use the IPO proceeds for a mix of debt reduction and business expansion.

Willing to apply for Meesho IPO? Check these key risks, strengths from RHP

Investors willing to apply for Meesho IPO can review the company's strengths and risks as outlined in its Red Herring Prospectus (RHP)

Vidya Wires IPO opens tomorrow: Bid or skip? Here's what experts suggest

The unlisted shares of Vidya Wires were trading at ₹57, commanding a grey market premium of ₹5 or 9.6 per cent on Tuesday